Valuation: HitGen Inc.

Market Cap 14B 2.1B 1.91B 1.76B 1.59B 3B 196B 3.11B 21.22B 8.39B 106B 7.88B 7.71B 334B P/E 2026 *
89.5x
P/E 2027 * 72x
Enterprise Value 14B 2.1B 1.91B 1.76B 1.59B 3B 196B 3.11B 21.22B 8.39B 106B 7.88B 7.71B 334B EV / Sales 2026 *
19.7x
EV / Sales 2027 * 16.3x
Free-Float
51.86%
Yield 2026 *
0.43%
Yield 2027 * 0.58%
1 day+0.72%
1 week-6.43%
Current month-5.03%
1 month-2.05%
3 months-9.09%
6 months+16.72%
Current year+48.83%
1 week 33.9
Extreme 33.90000000
41.66
1 month 31.22
Extreme 31.22
41.66
Current year 22.42
Extreme 22.42
47.58
1 year 21.46
Extreme 21.46
47.58
3 years 8.35
Extreme 8.35
47.58
5 years 8.35
Extreme 8.35
47.58
10 years 8.35
Extreme 8.35
61.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2012
Director of Finance/CFO 56 27/04/2023
Investor Relations Contact 38 01/07/2019
Director TitleAgeSince
Chairman 63 01/06/2012
Director/Board Member 73 01/02/2012
Director/Board Member 65 24/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
22/09/26 Buy

Chief Financial Officer

17,500 0.0044%
22/09/26 Buy

Executive/Senior Manager

25,000 0.0062%
22/09/26 Buy

Chief Executive Officer

94,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%-6.43%+44.45%+112.93% 2.1B
+1.15%-2.81%+55.79%+71.12% 66.37B
+0.84%-1.58%+9.26%+91.17% 58.86B
+0.60%+0.54%+26.08%+86.79% 55.22B
+0.48%-2.53%+9.73%+121.14% 47.21B
-2.69%-6.38%+19.19%+25.79% 42.45B
-0.70%+4.93%+17.77%+45.03% 36.44B
-2.50%-15.73%+135.31%+662.73% 35.19B
-0.46%-1.77%+82.57%+57.57% 32.66B
-0.83%+1.98%-38.27%+390.98% 26.73B
Average -0.33%-3.07%+36.19%+166.52% 40B
Weighted average by Cap. -0.20%-2.22%+35.06%+146.87%

Financials

2026 *2027 *
Net sales 712M 107M 96.97M 89.57M 80.81M 153M 9.98B 158M 1.08B 427M 5.39B 401M 392M 17.01B 861M 129M 117M 108M 97.62M 184M 12.06B 191M 1.3B 516M 6.51B 484M 474M 20.56B
Net income 155M 23.24M 21.1M 19.49M 17.58M 33.2M 2.17B 34.47M 235M 92.9M 1.17B 87.21M 85.37M 3.7B 194M 29.11M 26.43M 24.41M 22.02M 41.58M 2.72B 43.17M 294M 116M 1.47B 109M 107M 4.64B
Net Debt - -
Projected Income Statement - Annual - HitGen Inc.
Logo HitGen Inc.
HitGen Inc is a China-based company primarily engaged in the research, development and optimization of small molecule and nucleic acid-based new drug candidates using deoxyribonucleic acid (DNA) encoded chemical library (DEL) technology. Through the drug discovery and optimization platform, the Company provides clients with services such as screening and optimization of designated biological targets, customized DEL design and synthesis, synthesis and modification of certain designated compounds or nucleic acids and related biological evaluation. The Company is also engaged in the transfer of rights and interests in new drug research projects, capital operations and marketing activities. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States, France, the United Kingdom and Japan.
Employees
546
Date Price Change Volume
17/11/26 CN¥34.90 +0.72% 16,164,414
16/11/26 CN¥34.65 -8.79% 20,888,874
13/11/26 CN¥37.99 -7.00% 30,091,929
12/11/26 CN¥40.85 +5.23% 35,412,376
11/11/26 CN¥38.82 +4.08% 23,547,794
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - HitGen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
34.90CNY
Average target price
45.10CNY
Spread / Average Target
+29.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - HitGen Inc.
  1. Stock Market
  2. Stocks
  3. 688222 Stock